Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0777 for Cognitive Impairments in Schizophrenia
NCT00505076Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jul 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tpa-023 in schizophrenia, sponsored by University of California, Los Angeles. Started Jul 2007; status: completed.
02
Drugs
tpa-023
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00505076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505076.